![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Absence of a Significant Pharmacokinetic Interaction Between the HCV Protease Inhibitor Boceprevir and HIV-1 NNRTI Rilpivirine
|
|
|
Reported by Jules Levin
CROI 2013
Elizabeth G. Rhee, Hwa-ping Feng, Fengjuan Xuan, Wen H. Lin, Candice B. Smith, Yali Zhu, Joan R. Butterton
Merck, Whitehouse Station, NJ, USA
![CROI1.gif](../images/032913/032913-5/CROI1.gif)
![CROI2.gif](../images/032913/032913-5/CROI2.gif)
![CROI3.gif](../images/032913/032913-5/CROI3.gif)
![CROI4.gif](../images/032913/032913-5/CROI4.gif)
![CROI5.gif](../images/032913/032913-5/CROI5.gif)
![CROI6.gif](../images/032913/032913-5/CROI6.gif)
![CROI7.gif](../images/032913/032913-5/CROI7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|